Dual-energy CT for characterization of adrenal nodules: initial experience.

Published

Journal Article

OBJECTIVE: The purpose of this study was to determine whether use of dual-energy technique can improve the diagnostic performance of CT in the differential diagnosis of adrenal adenomas and metastatic lesions. SUBJECTS AND METHODS: Thirty-one adrenal nodules were prospectively identified in 17 patients who underwent dual-energy CT at 140 and 80 kVp. Attenuation measurements were performed for each nodule at both tube voltages. The mean attenuation change (increase or decrease) between 140 kVp and 80 kVp was determined for each adrenal nodule. RESULTS: Twenty-six adrenal nodules were benign adenomas (attenuation less than +10 HU or stability for at least 1 year). Five adrenal nodules were classified as metastatic (rapid growth in 1 year and history of extraadrenal malignancy). The mean attenuation change between 140 kVp and 80 kVp was 0.4 +/- 7.1 HU for adenomas and 9.2 +/- 4.3 HU for metastatic lesions (p < 0.003). Fifty percent of adenomas had an attenuation decrease at 80 kVp. All metastatic lesions had an attenuation increase at 80 kVp. With a decrease in attenuation at 80 kVp as an indicator of intracellular lipid within an adenoma, dual-energy CT has 50% sensitivity, 100% specificity, 100% positive predictive value, and 28% negative predictive value in the diagnosis of adenoma. CONCLUSION: A decrease in attenuation of an adrenal lesion between 140 kVp and 80 kVp is a highly specific sign of adrenal adenoma. However, because an increase in attenuation at 80 kVp is seen with metastatic lesions and some adenomas, the sensitivity of this test is low. These data suggest that dual-energy CT can be used to help differentiate some lipid-poor adrenal adenomas from metastatic lesions.

Full Text

Duke Authors

Cited Authors

  • Gupta, RT; Ho, LM; Marin, D; Boll, DT; Barnhart, HX; Nelson, RC

Published Date

  • June 2010

Published In

Volume / Issue

  • 194 / 6

Start / End Page

  • 1479 - 1483

PubMed ID

  • 20489086

Pubmed Central ID

  • 20489086

Electronic International Standard Serial Number (EISSN)

  • 1546-3141

Digital Object Identifier (DOI)

  • 10.2214/AJR.09.3476

Language

  • eng

Conference Location

  • United States